The Immune System – Products

New protein sequencing ‘proof-of-concept' method published in Nature shows promise in sequencing long, intact protein strands at single molecule resolution.

Rentschler Biopharma SE, announced the launch of an expanded service offering at its dedicated advanced therapies site in Stevenage, UK.

Scientists are constantly innovating newer technologies that allow them to understand nuances within these drugs and find ways to manufacture them more reliably.

Transgene announces the publication in the Journal for ImmunoTherapy of Cancer (JITC) of a peer-reviewed article which illustrates that TG6050 induces profound immune remodeling of the tumor microenvironment in animal models.

This application note outlines best practices for handling and analyzing IVT mRNA, ensuring accurate assessments of mRNA sizing, resolution and percent purity.

Sino Biological is at the forefront of accelerating Mpox research, offering a comprehensive portfolio of MPXV proteins and antibodies.

DNAnexus, Inc., provider of the Precision Health Data Cloud, and Galatea Bio, committed to 'Precision Health at Scale for All,' announced a strategic collaboration to enhance biomedical research and precision medicine.

On June 14, 2024, the U.S. FDA approved AstraZeneca's Durvalumab (IMFINZI®) for primary advanced or recurrent endometrial cancer with mismatch repair deficiency.

The long-term PERFECT observational study follows patients from successful Phase I/IIb of ProtheraCytes for the repair and regeneration of damaged cardiac tissues after severe heart attack.

This app note presents a novel protocol for generating larger quantities of invariant NK (iNK) cells from pluripotent stem cells (PSCs) using cytokine cocktails.